CDER Drug Safety Labeling Changes - 5/23/2022

Drug Safety-related Labeling Changes (SrLC) The SLC database has been updated with the following approved drug safety labeling changes. Drug Name Active Ingredient Application Number Application Type Supplement Date Database Updated CLEOCIN CLINDAMYCIN PHOSPHATE 050680 NDA 05/17/2022 05/20/2022 CLEOCIN CLINDAMYCIN PHOSPHATE 050767 NDA 05/17/2022 05/20/2022 MOXATAG AMOXICILLIN 050813 NDA 05/17/2022 05/20/2022 IMBRUVICA IBRUTINIB 210563 NDA 05/11/2022 05/18/2022 Manage Subscriptions  |  Unsubscribe All  |  Help This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA